Chemoprophylaxis in the prevention of leprosy

BMJ

Volumn 336, Issue 7647, 2008, Pages 730-731

  Smith, W Cairns S ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; DAPSONE; PLACEBO; RIFAMPICIN;

CHEMOPROPHYLAXIS; DISEASE TRANSMISSION; DRUG ABSORPTION; EDITORIAL; FEDERATED STATES OF MICRONESIA; HEALTH CARE POLICY; HUMAN; INCIDENCE; INDONESIA; LEPROSY; MYCOBACTERIUM LEPRAE; PRIORITY JOURNAL; RISK FACTOR; SINGLE DRUG DOSE;

HEALTH POLICY; HUMANS; LEPROSTATIC AGENTS; LEPROSY; RIFAMPIN;

EID: 41949124219     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39525.504688.80     Document Type: Editorial

References (11)

1. Moet FJ, Pahan D, Oskam L, Richardus JH. Effectiveness of single dose rifampicin in preventing leprosy in close contacts of patients with newly diagnosed leprosy: cluster randomised controlled trial. BMJ 2008; doi: 10.1136/bmj.39500.885752.BE.
2. Smith CM, Smith WCS. Chemoprophylaxis is effective in the prevention of leprosy in endemic countries: a systematic review and meta-analysis. J Infect 2000;41:137-42.
3. WHO. Elimination of leprosy as a public health problem. Wkly Epidemiol Rec 1998;73:308-12.
4. WHO. Leprosy global situation. Wkly Epidemiol Rec 2002;77:1-8.
5. Diletto C, Blanc L. Leprosy chemoprophylaxis in Micronesia. Lepr Rev 2000;71:S21-5.
6. Bakker MI, Hatta M, Kwenang A, van Benthem BH, van Beers SM, Klatser PR, et al. Prevention of leprosy using rifampicin as chemoprophylaxis. Am J Trop Med Hyg 2005;72:443-8.
7. Setia MS, Steinmaus C, Ho CS, Rutherford GW. The role of BCG in prevention of leprosy: a meta-analysis. Lancet Infect Dis 2006;6:162-70.
8. Alcais A, Alter A, Antoni G, Orlova M, Nguyen VT, Singh M, et al. Stepwise replication identifies a low-producing lymphotoxin-alpha allele as a major risk factor for early-onset leprosy. Nat Genet 2007;39:517-22.
9. Aseffa A, Brennan P, Dockrell H, Gillis T, Hussain R, Oskam L, et al. Report of the first meeting of the IDEAL (initiative for diagnostic and epidemiological assays for leprosy) consortium held at Armauer Hansen Research Institute, ALERT, Addis Ababa, Ethiopia on 24-27 October 2004. Lepr Rev 2005;76:147-59.
10. WHO. Global strategy for further reducing the leprosy burden and sustaining leprosy control activities (2006-2010). 2005. www.who.int/lep/resources/GlobalStrategy.pdf.
11. Oskam L, Bakker MI. Report of the workshop on the use of chemoprophylaxis in the control of leprosy held in Amsterdam, Netherlands on 14th December 2006. Lepr Rev 2007;78:173-85.